全球transplantation market根据Polaris市场研究的一项新的研究，预计尺寸预计将达到2028美元的195.2亿美元。betway苹果下载那个报告“移植市场份额，规模，趋势，行业分析报告，按产品类型（组织产品，免疫抑制药物和保存解决方案）;通过申请（器官和组织移植），通过地区使用（医院，移植中心和其他）;分部预测，2021-2028“详细了解当前市场动态，并提供未来市场增长分析。
In 2020, the tissue market segment for transplantation accounted for the largest share and is projected to retain its dominance. The rising cases of burn and accident cases all across the globe and high transplant products among patients in the developed economies favoring its growth. As per the estimates of the European Road Safety Observatory, there were around 102,362 accident cases in Spain, which has boosted the segment’s growth prospects in transplantation industry.
The organ transplantation segment is anticipated to grow at the fastest rate over the assessment period. Repetitive use of immuno-suppressants and rising organ transplant surgeries are the prominent market factors responsible for such a high growth rate. Moreover, advancements in transplantation technology followed by new product launches propelled the transparent procedures for kidneys, lungs, heart, tissue, and liver.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below://m.jiayuancx.com/Industry-analysis/Transplantation-market/Request-for-sample.
In this direction, in November 2020, Lupin introduced a generic version of an immune-suppressant drug, “Tacrolimus” in the U.S. territory, indicated for organ rejection in the allogenic heart, liver, and kidney transplants. In recent past few years, a high number of transplant procedures were recorded in Germany, France, the US., and the UK and the number is expected to rise in the coming years. Moreover, the presence of well-developed healthcare infrastructure and availability of skilled surgeons in these countries have favored the market growth for transplantation.
预计免疫抑制药物的市场部门将以在该研究中以利润丰厚的增长率增长。这种市场增长归因于其高效后器官移植和慢性疾病的普遍性。因此，预计对这些药物的市场需求的上涨需求以最快的速度增长。
预计保存市场部门将在评估期内见证大幅增长率。强大的政府资助干细胞研究和器官失败的上升案例是有利于市场部门在移植行业的增长前景的因素。
移植行业的市场参与者包括Stryker Corp.，Zimmer Biomet，Biolife解决方案，Medtronic，Teva Pharmaceutical，Abbvie Inc.，诺华国际，21世纪医学和Veloxis Pharmaceuticals。
betway苹果下载POLARIS市场研究已根据产品类型，申请，终用用途和地区分段进行移植市场报告：
移植，产品类型展望（收入 - 百万，2016 - 2028）
- 组织产品
- 免疫抑制药物
- 保存解决方案
Transplantation, Application Outlook (Revenue – USD Million, 2016 – 2028)
- 器官移植
- Tissue Transplant
Transplantation, End-Use Outlook (Revenue – USD Million, 2016 – 2028)
- Hospitals
- Transplant Centers
- Others
移植，由区域前景（收入 - 百万，2016 - 2028）
- North America
- U.S.
- 加拿大
- 欧洲
- 法国
- 德国
- UK
- 意大利
- 西班牙
- Netherlands
- Austria
- Asia Pacific
- China
- 印度
- Japan
- 马来西亚
- South Korea
- Indonesia
- Central & South America
- 墨西哥
- 巴西
- 阿根廷
- Middle East & Africa
- UAE
- Saudi Arabia
- 以色列
- South Africa